Universal - Advarra

Privacy Policy

Overview Advarra, Inc., doing business as Advarra®, and any of our subsidiaries or affiliates (collectively, “Advarra”), provide this policy so

Advarra’s Perspective on FDA’s Draft AI Guidance: Advancing Responsible Innovation

The U.S. Food and Drug Administration’s (FDA’s) recent draft guidance, “Considerations for the Use of Artificial Intelligence to Support Regulatory

The Story Behind Braid: How the Brand Reflects Advarra’s Vision for Data and AI in Clinical Research

Advarra partnered with PreHealth, a brand growth and experience agency, to create Braid, the identity for Advarra’s data and AI

regulation, regulatory framework, compliance with regulations, regulatory standards, regulatory authorities, government regulation, industry regulation, financial regulation, regulatory policy, regulatory reforms, regulatory oversight, regulatory requirements, regulatory guidelines, regulatory reporting, regulatory enforcement, regulatory changes, regulatory implications, tile, word, letter tiles, background

Are you prepared for ICH E6 (R3)?

The third revision (R3) of the ICH E6 Guideline for Good Clinical Practice represents a significant modernization of global clinical research standards. Research organizations must critically evaluate both their clinical priorities and operational procedures to ensure compliance.

The Executive Order that Brings Private Bioresearch Under Federal Oversight

The release of ICH E6(R3) in January 2025 marks the most significant evolution in Good Clinical Practice (GCP) guidelines in over a decade. More than a revision, E6(R3) marks a shift from traditional practices—making participant safety and data reliability not just priorities, but design drivers, and introducing risk-based proportionality as a foundational approach.

A digital interface showing a person interacting with transparent virtual icons related to compliance, such as "Policies," "Regulations," "Audit," "Guideline," "Requirement," and "Law." The word "COMPLIANCE" is prominently displayed in the center, surrounded by hexagonal icons representing various regulatory and legal concepts.

ICH E6(R3) Implementation Starts Now: Are You Ready?

Q&A with Advarra’s new Senior Vice President, FDA Regulatory Advisor, Jan Hewett

Clinical research drives medical progress. Advarra ensures participant safety and ethical standards through expert IRB oversight for life-changing therapies.

The Value of Clinical Research

Clinical research drives medical progress. Advarra ensures participant safety and ethical standards through expert IRB oversight for life-changing therapies.

An Interview with Jim Kremidas: What’s Next for the Association of Multisite Research Corporations (AMRC)

Launched in January 2025, the Association of Multisite Research Corporations (AMRC) was set up by its founding members to advance

Current State of Site-Sponsor-CRO Collaboration

Our webinar discusses key near-term trends and regulations and investigate persistent challenges frequently throwing even the most efficient teams off track. Advarra and industry representatives will dive deeper into achieving critical milestones across study startup, conduct, and close out that every project manager should optimize.

Oncology Research Pulse

Fostering Knowledge Exchange Across the Cancer Research Community Timely discussions. Expert perspectives. Illuminating the path to progress. Fostering Knowledge Exchange

Demystifying North American IRB/EC Requirements for International Research Professionals

Navigating research compliance often means addressing unseen challenges. Explore strategies to identify blind spots and strengthen oversight frameworks.